Neuroblastoma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Bagatell, R.; Park, J. R.; Acharya, S.; Aldrink, J.; Allison, J.; Alva, E.; Arndt, C.; Benedetti, D.; Brown, E.; Cho, S.; Church, A.; Davidoff, A.; Desai, A. V.; DuBois, S.; Fair, D.; Farinhas, J.; Harrison, D.; Huang, F.; Iskander, P.; Kreissman, S.; Macy, M.; Na, B.; Pashankar, F.; Pendyala, P.; Pinto, N.; Polites, S.; Rabah, R.; Shimada, H.; Slatnick, L.; Sokol, E.; Twist, C.; Vo, K.; Watt, T.; Wolden, S.; Zage, P.; Schonfeld, R.; Hang, L. |
| Title: | Neuroblastoma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease. |
| Keywords: | child; cancer staging; neoplasm staging; practice guideline; pathology; oncology; neuroblastoma; diagnosis; medical oncology; therapy; procedures; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 22 |
| Issue: | 6 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2024-08-01 |
| Start Page: | 413 |
| End Page: | 433 |
| Language: | English |
| DOI: | 10.6004/jnccn.2024.0040 |
| PUBMED: | 39151455 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
